dwn12088
dwn12088: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
Development Pipeline (1)
| Company | Phase |
|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) | Phase 2 |
Clinical Trials (1)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis
Frequently asked questions
Who is developing dwn12088?
dwn12088 is being developed by CTT PHARMACEUTICAL HOLDINGS, INC..
How many clinical trials involve dwn12088?
BioSniper tracks 1 clinical trial involving dwn12088.
Analyze CTT PHARMACEUTICAL HOLDINGS, INC. & dwn12088 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company